In the often tumultuous world of Hollywood, where relationships frequently falter under the spotlight, Michael J. Fox and ...

AbbVie is undervalued with strong EPS growth, rising immunology revenue, and a 3.43% yield. Check out ABBV's robust pipeline ...

Ray Figlewski couldn't possibly count the number of people he has engaged with at the Branford Road Race over the years. With thousands turning out to run, walk or volunteer in one of the crown jewels ...

Los Angeles Times readers give their thoughts on Bill Plaschke's poignant column on Parkinson's disease, the Dodgers and the ...

Alzheimer’s disease is a serious condition that mostly affects older people. It causes memory loss, confusion, and changes in how a person thinks and behaves. It’s the most common cause of dementia, a ...

"Parkinson's disease does not have to control a patient's life," says Dr. Aasef Shaikh. "Diagnosis and ongoing management are ...

Mayo Clinic's Neurobiology of Parkinson's Disease and Related Disorders Lab showed that small aggregates of alpha-synuclein ...

Mayo Clinic's Neurobiology of Parkinson's Disease and Related Disorders Lab is deciphering the role of aggregation and ...

Lewy body disease is a stealthy and relentless brain disorder that affects memory, movement, and core body functions. It ...

Ambio will test ibogaine, an experimental, naturally occurring psychedelic, as a therapy for neurodegenerative conditions ...

A new study suggests long-term exposure to chemicals used to keep fairways green may be tied to an increased risk of ...

Psilocybin therapy improved cognitive performance, reduced mood dysfunction, motor, and nonmotor symptoms in patients with Parkinson disease.